Bright Minds Biosciences Inc. (DRUG)
NASDAQ·Healthcare·Biotechnology
$88.62
-1.80%
Mkt Cap $692.02M
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (5 analysts)
$136.50
Range $126.00 – $147.00
Implied Upside
+54.0%
Consensus $136.50 vs current $88.62